K
57
4
DOW
34
4
KMX
64
6
LRCX
45
6
PAYX
51
4
PCAR
56
3
V
66
6
FRT
45
6
MU
36
5
SYK
68
4
NAVI
47
3
BK
72
4
EFX
36
4
ORLY
60
7
LB
41
7
VTR
54
5
FLS
75
2
DD
60
4
HAL
60
2
AXP
69
3
K
57
4
DOW
34
4
KMX
64
6
LRCX
45
6
PAYX
51
4
PCAR
56
3
V
66
6
FRT
45
6
MU
36
5
SYK
68
4
NAVI
47
3
BK
72
4
EFX
36
4
ORLY
60
7
LB
41
7
VTR
54
5
FLS
75
2
DD
60
4
HAL
60
2
AXP
69
3
Financhill
Back

ClearPoint Neuro Vs. Perspective Therapeutics Industry Stock Comparison

Sell
22

CLPT
ClearPoint Neuro

Last Price:
11.83
Seasonality Move:
21.75%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
22
ClearPoint Neuro (CLPT) is a Sell

Is ClearPoint Neuro a Buy, Sell or Hold?

  • The current ClearPoint Neuro [CLPT] share price is $11.09. The Score for CLPT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • CLPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLPT Stock Price Chart

What is ClearPoint Neuro's stock price today?

  • The ClearPoint Neuro share price today is $11.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLPT is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

CLPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 41.95 Sell
Chaikin Money Flow: 38882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.25 - 13.15) Sell
Bollinger Bands (100): (8.18 - 12.84) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

CLPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11 Buy
20-day SMA: 12.04 Sell
50-day SMA: 11.92 Sell
200-day SMA: 8.35 Buy
8-day EMA: 11.18 Sell
20-day EMA: 11.65 Sell
50-day EMA: 11.59 Sell
200-day EMA: 9.27 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

ClearPoint Neuro Earnings Growth & CLPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.09 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

ClearPoint Neuro Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):